Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice

被引：0
|
作者：
Seema A. Patil
Ankur Rustgi
Patricia Langenberg
Raymond K. Cross
机构：
[1] University of Maryland School of Medicine,Division of Gastroenterology and Hepatology, Department of Medicine
[2] University of Maryland,Department of Epidemiology and Public Health, School of Medicine
[3] Veterans Affairs,undefined
[4] Maryland Heath Care System,undefined
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Crohn’s disease; Anti-TNF therapy; Infliximab; Adalimumab; Certolizumab pegol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：209 / 215
页数：6
相关论文
共 50 条
  • [1] Comparative Effectiveness of Anti-TNF Agents for Crohn's Disease in a Tertiary Referral IBD Practice
    Patil, Seema A.
    Rustgi, Ankur
    Langenberg, Patricia
    Cross, Raymond K.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (01) : 209 - 215
  • [2] Comaparison of Effectiveness and Perisitence Anti-TNF drugs on Perianal Fistulizing Crohn's Disease: A Single Tertiary IBD Referral Center Experience
    Koc, O.
    Acehan, M. F.
    Yilmaz, V
    Guvenir, S. T.
    Toruner, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1976 - i1977
  • [3] Utilisation of anti-TNF agents in phlegmonous Crohn's disease: an Australian tertiary referral centre experience
    Chiu, L.
    Digby-Bell, J.
    Seah, J.
    Melton, S.
    Taylor, K.
    Sparrow, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S542 - S543
  • [4] Anti-TNF agents in Crohn's disease
    Van Assche, G
    Rutgeerts, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (01) : 103 - 111
  • [5] Comparative Effectiveness and Safety of Anti-TNF Agents for Crohn's Disease in Biologic-Naive Patients
    Singh, Siddharth
    Sangaralingham, Lindsey R.
    Heien, Herbert
    Anderson, Stephanie S.
    Shah, Nilay
    Loftus, Edward V.
    GASTROENTEROLOGY, 2015, 148 (04) : S175 - S175
  • [6] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
  • [7] Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies
    Sharip, Mohmmed Tauseef
    Nishad, Nilanga
    Pillay, Lushen
    Goordoyel, Nilkantsingh
    Goerge, Samuel
    Subramanian, Sreedhar
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [8] Anti-TNFα agents: ulcerative colitis or Crohn's disease
    Reactions Weekly, 2019, 1763 (1) : 7 - 7
  • [9] Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [10] Long-term effectiveness of anti-TNF agents in symptomatic stricturing Crohn's disease
    Rodriguez-Lago, I.
    Del Hoyo, J.
    Casanova, M. J.
    Fernandez-Clotet, A.
    Garcia, M. J.
    Ferreiro-Iglesias, R.
    Piqueras, M.
    Suarez, C.
    Lopez-Garcia, A.
    Arroyo, M.
    Sierra, M.
    Delgado-Guillena, P.
    Guerra, I.
    Merino, O.
    Arranz, L.
    Llao, J.
    Plaza, R.
    Molina, G.
    Torres, P.
    Perez-Galindo, P.
    Herrera-deGuise, C.
    Armesto, E.
    Mesonero, F.
    Aguirre, U.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S467 - S468
12345